Skip to content
value.today

ExploraMed NC7, Inc.

Formerly ExploraMed NC7, LLC

Total raised
$182 M
5 rounds on record
Latest round
$81 M
Jan 2024
First round on record
Jan 2015
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ExploraMed NC7, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2024$81 MNo. 5$50 to $250 million

ExploraMed NC7, Inc.: Raise no. 5, Jan 2024

Investors in this round

30 investors had bought by the notice of Jan 22, 2024: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$81 M of $107 M offered; $26 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kelly Kennedy · Executive Officer
  • Sarah O'Leary · Executive Officer, Director
  • Scott Becker · Executive Officer
  • Addison Wright · Director
  • Avinash Amin · Director
  • Michael Carusi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sarah O'Leary, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Jan 22, 2024. Read the notice at the SEC.

equity, optionsSEC
Sep 2020$33 MNo. 4$10 to $50 million

ExploraMed NC7, Inc.: Raise no. 4, Sep 2020

Investors in this round

35 investors had bought by the notice of Oct 1, 2020: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $45 M offered; $13 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew W Chmyz · Executive Officer
  • Laura Chambers · Executive Officer, Director
  • Ivy W Ross · Director
  • Joshua Makower · Director
  • Michael Carusi · Director
  • Nina W Richardson · Director
  • Robert W Croce · Director
  • Stacy W Feld · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Chmyz, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 1, 2020. Read the notice at the SEC.

equitySEC
Jul 2019$23 MNo. 3$10 to $50 million

ExploraMed NC7, Inc.: Raise no. 3, Jul 2019

Investors in this round

7 investors had bought by the notice of Aug 15, 2019: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $29 M offered; $7 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew W. Chmyz · Executive Officer
  • Naomi Kelman · Executive Officer, Director
  • Ivy W. Ross · Director
  • Joshua W. Makower · Director
  • Michael Carusi · Director
  • Nina W. Richardson · Director
  • Robert W. Croce · Director
  • Stacy W. Feld · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Naomi Kelman, President & CEO. Source: SEC Form D, newest notice filed Aug 15, 2019. Read the notice at the SEC.

equitySEC
Nov 2017$27 MNo. 2$10 to $50 million

ExploraMed NC7, Inc.: Raise no. 2, Nov 2017

Investors in this round

12 investors had bought by the notice of Dec 12, 2017: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $31 M offered; $4 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew W. Chmyz · Executive Officer
  • Naomi G. Kelman · Executive Officer, Director
  • Ivy W. Ross · Director
  • Joshua W. Makower · Director
  • Michael K. Carusi · Director
  • Nina W. Richardson · Director
  • Robert K. Anderson · Director
  • Robert W. Croce · Director
  • Stacy W. Feld · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Chmyz, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 12, 2017. Read the notice at the SEC.

equitySEC
Jan 2015$17 MNo. 1$10 to $50 million

ExploraMed NC7, Inc.: Raise no. 1, Jan 2015

Investors in this round

43 investors had bought by the notice of Mar 9, 2015: 43 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $18 M offered; $0 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Naomi Kelman · Executive Officer, Director
  • Joshua Makower · Director
  • Michael Carusi · Director
  • Michael Chuisano · Director
  • Robert Anderson · Director
  • Robert Croce · Director
  • Ryan Drant · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Naomi Kelman, President/CEO. Source: SEC Form D and 1 amendment, newest notice filed Mar 9, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ExploraMed NC7, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2024).

    SEC Form D · Jan 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2024

That is all the official record says: ExploraMed NC7, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of ExploraMed NC7, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 43 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ExploraMed NC7, Inc.
NameRoleNamed in
Kelly KennedyExecutive officerJan 2024
Sarah O'LearyExecutive officerJan 2024
Scott BeckerExecutive officerJan 2024
Andrew W ChmyzExecutive officerOct 2020
Laura ChambersExecutive officerOct 2020
Andrew W. ChmyzExecutive officerAug 2019
Naomi KelmanExecutive officerAug 2019
Naomi G. KelmanExecutive officerDec 2017
Addison WrightDirectorJan 2024
Avinash AminDirectorJan 2024
Michael CarusiDirectorJan 2024
Sarah O'LearyDirectorJan 2024
Ivy W RossDirectorOct 2020
Joshua MakowerDirectorOct 2020
Laura ChambersDirectorOct 2020
Nina W RichardsonDirectorOct 2020
Robert W CroceDirectorOct 2020
Stacy W FeldDirectorOct 2020
Ivy W. RossDirectorAug 2019
Joshua W. MakowerDirectorAug 2019
Naomi KelmanDirectorAug 2019
Nina W. RichardsonDirectorAug 2019
Robert W. CroceDirectorAug 2019
Stacy W. FeldDirectorAug 2019
Michael K. CarusiDirectorDec 2017
Naomi G. KelmanDirectorDec 2017
Robert K. AndersonDirectorDec 2017
Michael ChuisanoDirectorMar 2015
Robert AndersonDirectorMar 2015
Robert CroceDirectorMar 2015
Ryan DrantDirectorMar 2015